Clinical Research Division, Fred Hutch
Dr. Mazyar Shadman is a blood cancer specialist who focuses on lymphoid malignancies. He is involved in clinical research using novel therapeutic agents for lymphoma and chronic lymphocytic leukemia, or CLL, as well as immunotherapy (specifically CAR T cell therapy) for lymphoid neoplasms and blood stem cell transplant for hematologic malignancies. His goal is to identify the best treatment sequence or combination for patients with high-risk lymphoma and CLL.
Attending Physician, Hematologic Malignancies
Seattle Cancer Care Alliance
Assistant Professor, Medical Oncology Division
University of Washington School of Medicine
M.D., Tehran University of Medical Sciences, 2004
Internal Medicine Residency, Cleveland Clinic, 2008-2011
Hematology and Medical Oncology fellowship, University of Washington/Fred Hutchinson Cancer Research Center, 2011-2014
M.P.H., Cancer Epidemiology, University of Washington, 2008
Therapeutic clinical trials in lymphoid malignancies with a focus on chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
Clinical outcome research in hematopoietic cell transplantation
Epidemiology of hematologic malignancies
Study Number: 9738
Study Number: S1608
Study Number: 9703
Study Number: 9727
Study Number: 9837
Study Number: 9905
Study Number: RG1003500
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email email@example.com or call 206.667.2210.